Orexin agonist

Search documents
Alkermes (ALKS) FY Conference Transcript
2025-06-09 15:00
Alkermes (ALKS) FY Conference June 09, 2025 10:00 AM ET Speaker0 Great. Good morning, everyone. Thanks so much for joining us. I'm really pleased to be joined by Richard Pops, chairman and CEO of Alkermes. Thanks so much, Rich, for joining us. Speaker1 Thanks for having us. Speaker0 Yeah. Maybe before we jump into your commercial business and your pipeline, I can start with a big picture question here. Alkermes has been undergoing this evolution over the last couple years. Maybe just level set for us. What ...
Centessa Pharmaceuticals (CNTA) 2025 Conference Transcript
2025-06-04 16:40
Centessa Pharmaceuticals (CNTA) 2025 Conference June 04, 2025 11:40 AM ET Speaker0 Thank you for sorry. I don't know. It's so loud. Thank you for joining Jefferies Global Healthcare Conference. My name is Kelly Shi, one of the equity analyst on biotech team. And in this fair chat session, we are very pleased to have Mario from Sentosa. And Mario, could you give us an introduction of yourself briefly? Speaker1 Yeah, good morning everybody. Great to be here with you all. Thank you for the invitation, Connie. ...
Centessa Pharmaceuticals (CNTA) Conference Transcript
2025-02-06 19:00
Centessa Pharmaceuticals (CNTA) Conference February 06, 2025 01:00 PM ET Company Participants Debjit Chattopadhyay - Managing DirectorMario Accardi - President of the Orexin Program Debjit Chattopadhyay Good afternoon, and thank you for joining Guggenheim's second, Smithcap conference. I am Devchit, and joining me from Syntesa is Mario Carty, the president of the Orexin program. Did I get that right? Mario Accardi You did. Yes, Doug. Hi. Great to be here with you. Debjit Chattopadhyay Well, it's been a very ...